short acting glp 1 agonists GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes GLP-1 receptor agonists and next-generation

8 (6), e70132

Diabetes Care 42(10):19301938 Lunghi C, Daniele G, Binda P et al (2019) Altered visual plasticity in morbidly obese subjects

Any perceived energy increase results indirectly from improved blood sugar control, weight loss, and resolution of obesity-related symptoms rather than pharmacological stimulation

Lpez-Padrs C, Salord N, Alves C, et al

Titration Complexities Slow titration, while necessary to reduce side effects, delays the onset of maximum efficacy

Summary: New GLP-1 and related drugs are likely to become available over the next 3-5 years, and this drug class will likely be approved for additional indications